26 February 2014 - Deborah Wilkes
Archived
Armstrong Pharmaceuticals has run into trouble with its plan to get an OTC asthma inhaler back on the market in the US under the established Primatene brand name.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.